Charles River Laboratories International, Inc.
NYSE: CRL0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- New York Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- James C. Foster
- Employees
- 18,700
- Headquarters
- Wilmington, United States
- IPO year
- 2000
- Market cap
- $9.7B
- Website
- https://www.criver.com
Loading CRL…
Loading profile data…Frequently asked questions about CRL
What does Charles River Laboratories International, Inc. (CRL) do?
Charles River Laboratories International, Inc. operates as a contract research organization (CRO), providing essential preclinical services to the pharmaceutical and biotechnology industries. Its core business revolves around assisting clients with drug discovery, non-clinical development, and thorough safety testing, with its services extending...
Where does CRL trade?
Charles River Laboratories International, Inc. (CRL) trades on the New York Stock Exchange.
What sector is CRL in?
Charles River Laboratories International, Inc. (CRL) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of Charles River Laboratories International, Inc.?
James C. Foster is the chief executive officer of Charles River Laboratories International, Inc. (CRL).
Where is Charles River Laboratories International, Inc. headquartered?
Charles River Laboratories International, Inc. is headquartered in United States.
Does CRL pay a dividend?
Charles River Laboratories International, Inc. (CRL) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did CRL go public?
Charles River Laboratories International, Inc. (CRL) completed its initial public offering in 2000.